E
Ewa Toporowska-Kowalska
Researcher at Medical University of Łódź
Publications - 46
Citations - 569
Ewa Toporowska-Kowalska is an academic researcher from Medical University of Łódź. The author has contributed to research in topics: Percutaneous endoscopic gastrostomy & Gastrostomy. The author has an hindex of 11, co-authored 44 publications receiving 489 citations.
Papers
More filters
Journal ArticleDOI
Switching Between Infliximab Originator and Biosimilar in Paediatric Patients with Inflammatory Bowel Disease. Preliminary Observations.
Joanna Sieczkowska,Dorota Jarzębicka,Aleksandra Banaszkiewicz,Anna Plocek,Agnieszka Gawrońska,Ewa Toporowska-Kowalska,Grzegorz Oracz,Monika Meglicka,Jaroslaw Kierkus +8 more
TL;DR: Switching from infliximab originator to its biosimilar seems to be a safe option in children with CD and the biosimilar was just as effective as the originator after the switch.
Journal ArticleDOI
Insulin sensitivity in Type 1 diabetic children and adolescents.
Agnieszka Szadkowska,Iwona Pietrzak,Beata Mianowska,Joanna Bodalska-Lipińska,H. A. Keenan,H. A. Keenan,Ewa Toporowska-Kowalska,Wojciech Młynarski,Jerzy Bodalski +8 more
TL;DR: The aim is to estimate insulin sensitivity in Type 1 diabetic children and adolescents, and assess the relationship between insulin sensitivity and clinical markers of adiposity and parameters of the metabolic syndrome.
Journal ArticleDOI
Monotherapy with infliximab versus combination therapy in the maintenance of clinical remission in children with moderate to severe Crohn disease.
Jarosław Kierkuś,Barbara Iwańczak,Agnieszka Wegner,Maciej Dadalski,Urszula Grzybowska-Chlebowczyk,Izabella Łazowska,Jolanta Maślana,Ewa Toporowska-Kowalska,Grażyna Czaja-Bulsa,Grażyna Mierzwa,Bartosz Korczowski,Elżbieta Czkwianianc,Alicja Żabka,Edyta Szymańska,Elzbieta Krzesiek,Sabina Więcek,Malgorzata Sladek +16 more
TL;DR: Twenty-six weeks likely represent the safe duration of combined IFX/immunomodulatory therapy in the authors' sample of pediatric patients with CD.
Journal Article
Asthma and gastroesophageal reflux in children.
TL;DR: Beneficial effect of antireflux therapy on the course of asthma has been emphasized and it is recommended in all patients with concurrent asthma and GER, irrespective of severity of clinical GER symptoms, even in those with silent GER.
Journal ArticleDOI
Induction Therapy With Biosimilar Infliximab in Children With Crohn Disease.
Joanna Sieczkowska-Golub,Monika Meglicka,Anna Plocek,Aleksandra Banaszkiewicz,Dorota Jarzębicka,Ewa Toporowska-Kowalska,Agnieszka Gawrońska,Grzegorz Oracz,Jaroslaw Kierkus +8 more
TL;DR: The profile appears similar to that reported for the reference infliximab, which was licensed for use in patients with Crohn disease (CD) based on the extrapolation of data from preclinical studies and clinical trials in rheumatology indications.